Results 261 to 270 of about 3,288,469 (360)

Patients with chronic kidney disease stage 3b: do general practitioners and nephrologists follow KDIGO guidelines? [PDF]

open access: yesJ Bras Nefrol
Macedo JG   +3 more
europepmc   +1 more source

Supplementary Material for: Arginine and Asymmetric Dimethylarginine in Puromycin Aminonucleoside-Induced Chronic Kidney Disease in the Rat

open access: green, 2011
Gin‐Fu Chen   +7 more
openalex   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Does Time in a Day Alters Uroflowmetery: A Prospective Experience With Population of Nepal

open access: yesInternational Journal of Clinical Practice
Deepak Kumar Yadav   +6 more
doaj   +1 more source

Comparative Analysis of Kidney and Simultaneous Pancreas-Kidney Transplantation: Long-Term Outcomes in Type 1 Diabetic Patients with End-Stage Kidney Disease. [PDF]

open access: yesJ Clin Med
Ziaja J   +11 more
europepmc   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

open access: yesAdvanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Home - About - Disclaimer - Privacy